CASCIO, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 4.354
EU - Europa 3.083
AS - Asia 1.777
SA - Sud America 317
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 9.581
Nazione #
US - Stati Uniti d'America 4.307
FI - Finlandia 731
CN - Cina 675
DE - Germania 665
SG - Singapore 632
IT - Italia 480
UA - Ucraina 410
BR - Brasile 274
RU - Federazione Russa 198
GB - Regno Unito 155
HK - Hong Kong 152
IE - Irlanda 116
SE - Svezia 111
PL - Polonia 70
VN - Vietnam 61
KR - Corea 48
BE - Belgio 43
IN - India 34
AR - Argentina 24
FR - Francia 22
MX - Messico 22
PK - Pakistan 21
TR - Turchia 21
IR - Iran 20
AT - Austria 19
JP - Giappone 17
IQ - Iraq 16
ZA - Sudafrica 14
CA - Canada 13
BD - Bangladesh 12
ID - Indonesia 11
NL - Olanda 11
RO - Romania 11
CZ - Repubblica Ceca 8
ES - Italia 8
CI - Costa d'Avorio 7
MA - Marocco 7
UZ - Uzbekistan 7
CH - Svizzera 6
EU - Europa 6
MY - Malesia 6
SA - Arabia Saudita 6
TN - Tunisia 6
CR - Costa Rica 5
EC - Ecuador 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
LT - Lituania 4
PY - Paraguay 4
AZ - Azerbaigian 3
CO - Colombia 3
GE - Georgia 3
IL - Israele 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PH - Filippine 3
TH - Thailandia 3
UY - Uruguay 3
BG - Bulgaria 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KH - Cambogia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
PA - Panama 1
RS - Serbia 1
SD - Sudan 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 9.581
Città #
Ashburn 526
Fairfield 373
Singapore 318
Ann Arbor 312
Woodbridge 284
Chandler 266
Houston 240
Wilmington 240
Jacksonville 224
Hong Kong 148
Seattle 136
Dublin 116
Cambridge 112
Palermo 105
The Dalles 102
Nanjing 95
Beijing 93
Dallas 93
Medford 90
New York 84
Moscow 82
Hefei 70
Los Angeles 64
Princeton 58
Zgierz 58
Boardman 54
Des Moines 51
Tulsa 51
Altamura 50
Brussels 43
Lawrence 35
Buffalo 33
Santa Clara 33
Shenyang 31
Venice 31
Ludwigshafen am Rhein 30
Nanchang 30
Jinan 29
Dearborn 28
São Paulo 28
San Mateo 27
Seongnam 27
Milan 25
Ho Chi Minh City 24
Munich 24
San Diego 24
Changsha 22
Helsinki 22
Jiaxing 21
Seoul 19
Hebei 18
Ningbo 18
Tianjin 18
Kitzingen 17
Nuremberg 17
Tokyo 16
Verona 16
Council Bluffs 15
Atlanta 13
Auburn Hills 13
Frankfurt am Main 13
London 13
Guangzhou 12
Hangzhou 12
Hanoi 12
Phoenix 12
Rio de Janeiro 12
San Paolo di Civitate 12
Zhengzhou 12
Johannesburg 11
Kunming 11
Lancaster 11
Tehran 11
Kumar 10
Poplar 10
Stockholm 10
Taizhou 10
Denver 9
Falls Church 9
Taiyuan 9
Warsaw 9
Boston 8
Brooklyn 8
Orem 8
Saint Petersburg 8
Vienna 8
Abidjan 7
Baghdad 7
Brasília 7
Columbus 7
Melfi 7
Mumbai 7
Turku 7
Lanzhou 6
Redwood City 6
Tashkent 6
Ankara 5
Chennai 5
Curitiba 5
Dhaka 5
Totale 5.599
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 342
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 257
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 257
Founder mutations in BRCA1 and BRCA2 genes 246
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 229
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 226
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 224
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 220
Ductal lavage: a way of carefully tracing the breast-secreting duct 205
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 204
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 202
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 196
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 193
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 193
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 191
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 190
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 189
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 189
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 188
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 187
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 186
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 184
A missense mutation associated to early onset breast cancer in a sicilian woman. 180
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 179
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 176
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 169
Insulin-dependent leptin expression in breast cancer cells. 169
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer 168
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 165
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 164
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER 161
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes 160
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli 157
BRCA1 missense variants of uncertain clinical significance in unaffected and breast/ovarian cancer of the Sicilian population. 154
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 154
DNA-aneuploidy and high SPF and specific p53 mutations are independent prognostic factors in colorectal cancer (CRC). 153
TP53, h-k-ras,p16ink4a gene molecular analysis in salivary gland tumors 152
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression 150
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 146
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. 143
Mutational analysis of BRCA1 gene in sicilian patient at risk for inherited breast and/or ovarian cancer: experience of reference center the biomolecular characterization of neoplasm and genetic screening of hereditary tumors. 139
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 137
DNA-Aneuploidy, High SPF and Specific P53 Mutations are Indipendent Prognostic Factors in Colorectal Cancer (CRC) 135
DNA aneuploidy, high SPF and specific p53 mutations are independent prognostic factors in colorectale cancer (CRC) 135
TP53 mutations are not prognostic independent indicators in bladder cancer. 129
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 129
The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships 125
HPV-INFECTION IN ORAL SQUAMOUS CELL CARCINOMA IN RELATION WITH S-PHASE KINASE-INTERACTING PROTEIN 2 AND P27KIP1 PROTEIN EXPRESSION 123
Detection and clinical relevance of free circulating tumor DNA in blood of patients with gastrointestinal cancer 120
Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. 119
Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. 108
TP53 mutation are not prognostic indipendent indicators in bladder cancer 107
TP53 in exon 5 and s-Phase fraction but not mutations in Ras gen family and DNA-ploidy are indipendent indicators in laryngeal squamous cell carcinoma 106
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 105
TP53 mutations are not prognostic indipendent indicators in bladder cancer 92
Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1alpha in human colorectal cancer. 84
Use of saliva as a biological medium in non invasive screening for oral cancer 80
TRANSKETOLASE-LIKE 1 EXPRESSION IN PAPILLARY THYROID CARCINOMAS SMALLER THAN 1.5 CM 67
null 3
null 3
PRC2 allosteric modulation an alternative strategy in drug discovery for the epigenetic diseases 1
Totale 9.645
Categoria #
all - tutte 30.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021432 0 0 0 0 0 18 72 26 115 35 90 76
2021/2022667 31 160 10 34 30 13 47 25 78 89 36 114
2022/2023824 107 151 7 76 124 101 45 56 107 7 38 5
2023/2024468 22 59 36 20 23 118 43 67 1 8 1 70
2024/20251.162 17 75 54 89 49 26 86 106 101 187 135 237
2025/20261.720 409 122 306 325 349 209 0 0 0 0 0 0
Totale 9.645